C
CAMP
Camp4 Therapeutics Corp.
4.490
0.0000.00%After Hours: 4.400 -0.090 -2.00%18:07 04/10 EDT
OPEN/PREV CLOSE4.510/4.490
TODAY RANGE4.450-4.840
VOL60.99K
MARKET CAP233.12M
52 WEEK RANGE1.305-7.75
AVG VOL (3M)187.12K
% TURNOVER0.12%
TURNOVER--
P/E (TTM)-1.6966
% RANGE8.02%
EPS(TTM)-2.6465
P/E(FORWARD)-0.5185
P/B4.885
BVPS0.9191
DIVIDEND--
P/S66.62
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP195.40M
SHARES OUTSTANDING51.92M
NEXT EARNINGS05/11-05/15
FREE FLOAT43.52M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·04/03 20:43
Camp4 Therapeutics files Form 3 for director Michael F. MacLean
Benzinga·04/02 15:49
Amazon To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Thursday
Dow Jones·04/02 14:59
CAMP4 Therapeutics Is Maintained at Outperform by Leerink Partners
Dow Jones·04/02 14:59
CAMP4 Therapeutics Price Target Raised to $9.00/Share From $8.00 by Leerink Partners
TipRanks·04/02 10:11
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
TipRanks·03/24 11:29
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board
Reuters·03/24 11:03
Camp4 appoints Michael MacLean to board, expands board to nine directors
Reuters·03/24 11:00
CAMP4 APPOINTS MICHAEL MACLEAN TO ITS BOARD OF DIRECTORS
Dow Jones·03/24 11:00
Press Release: CAMP4 Appoints Michael MacLean to its Board of Directors
Dow Jones·03/24 11:00
*CAMP4 Appoints Michael MacLean to Its Bd of Directors
TipRanks·03/12 16:00
Biotech Alert: Searches spiking for these stocks today
Seeking Alpha·03/07 13:45
Camp4 Therapeutics: Strong Cash Runway As CMP-002 Moves Toward Human Trials